127 related articles for article (PubMed ID: 18344519)
1. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis.
Kang KH; Park SY; Rho SB; Lee JH
Cardiovasc Res; 2008 Jul; 79(1):150-60. PubMed ID: 18344519
[TBL] [Abstract][Full Text] [Related]
2. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
3. The effects of the inhibition of inducible nitric oxide synthase on angiogenesis of epithelial ovarian cancer.
Malone JM; Saed GM; Diamond MP; Sokol RJ; Munkarah AR
Am J Obstet Gynecol; 2006 Apr; 194(4):1110-6; discussion 1116-8. PubMed ID: 16580304
[TBL] [Abstract][Full Text] [Related]
4. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin II on human endothelial cells survival signalling pathways and its angiogenic response.
Kou B; Vatish M; Singer DR
Vascul Pharmacol; 2007 Oct; 47(4):199-208. PubMed ID: 17804301
[TBL] [Abstract][Full Text] [Related]
6. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
[TBL] [Abstract][Full Text] [Related]
8. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-binding protein-5 (IGFBP-5) acts as a tumor suppressor by inhibiting angiogenesis.
Rho SB; Dong SM; Kang S; Seo SS; Yoo CW; Lee DO; Woo JS; Park SY
Carcinogenesis; 2008 Nov; 29(11):2106-11. PubMed ID: 18775916
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
11. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
12. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
Jung MH; Lee SH; Ahn EM; Lee YM
Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
[TBL] [Abstract][Full Text] [Related]
13. Suppressing Akt phosphorylation and activating Fas by safrole oxide inhibited angiogenesis and induced vascular endothelial cell apoptosis in the presence of fibroblast growth factor-2 and serum.
Zhao J; Miao J; Zhao B; Zhang S; Yin D
Int J Biochem Cell Biol; 2006; 38(9):1603-13. PubMed ID: 16702019
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of ethoxidine, a topoisomerase I inhibitor, in the cellular processes leading to angiogenesis on endothelial cells.
Clere N; Faure S; Helesbeux JJ; Duval O; Andriantsitohaina R
Carcinogenesis; 2011 Mar; 32(3):286-95. PubMed ID: 21135154
[TBL] [Abstract][Full Text] [Related]
16. Resistin regulates human choriocarcinoma cell invasive behaviour and endothelial cell angiogenic processes.
Di Simone N; Di Nicuolo F; Sanguinetti M; Castellani R; D'Asta M; Caforio L; Caruso A
J Endocrinol; 2006 Jun; 189(3):691-9. PubMed ID: 16731799
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the metabolic changes underlying growth factor angiogenic activation: identification of new potential therapeutic targets.
Vizán P; Sánchez-Tena S; Alcarraz-Vizán G; Soler M; Messeguer R; Pujol MD; Lee WN; Cascante M
Carcinogenesis; 2009 Jun; 30(6):946-52. PubMed ID: 19369582
[TBL] [Abstract][Full Text] [Related]
19. Abnormal vessel formation in the choroid of mice lacking tissue inhibitor of metalloprotease-3.
Janssen A; Hoellenriegel J; Fogarasi M; Schrewe H; Seeliger M; Tamm E; Ohlmann A; May CA; Weber BH; Stöhr H
Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2812-22. PubMed ID: 18408187
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
